Cubist Systematic Strategies LLC lessened its position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 8.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 314,798 shares of the real estate investment trust's stock after selling 27,470 shares during the quarter. Cubist Systematic Strategies LLC's holdings in Healthpeak Properties were worth $6,365,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also made changes to their positions in the business. Mercer Global Advisors Inc. ADV lifted its holdings in shares of Healthpeak Properties by 29.4% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 38,379 shares of the real estate investment trust's stock valued at $778,000 after buying an additional 8,726 shares during the period. Algert Global LLC acquired a new stake in shares of Healthpeak Properties during the 4th quarter worth approximately $4,289,000. Ameriprise Financial Inc. increased its position in Healthpeak Properties by 15.6% in the 4th quarter. Ameriprise Financial Inc. now owns 6,671,491 shares of the real estate investment trust's stock valued at $134,028,000 after acquiring an additional 902,171 shares during the period. BNP Paribas Financial Markets bought a new position in Healthpeak Properties during the 4th quarter valued at $29,580,000. Finally, Benjamin Edwards Inc. boosted its stake in shares of Healthpeak Properties by 23.1% during the 4th quarter. Benjamin Edwards Inc. now owns 32,700 shares of the real estate investment trust's stock worth $663,000 after acquiring an additional 6,141 shares in the last quarter. 93.57% of the stock is owned by institutional investors and hedge funds.
Insider Activity at Healthpeak Properties
In related news, CEO Scott M. Brinker purchased 2,930 shares of the business's stock in a transaction dated Thursday, July 31st. The shares were purchased at an average cost of $17.06 per share, for a total transaction of $49,985.80. Following the completion of the acquisition, the chief executive officer owned 210,416 shares in the company, valued at approximately $3,589,696.96. This trade represents a 1.41% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders have bought 8,783 shares of company stock valued at $150,129 in the last quarter. Corporate insiders own 0.23% of the company's stock.
Analyst Ratings Changes
A number of analysts recently issued reports on the company. Wells Fargo & Company reduced their price objective on Healthpeak Properties from $20.00 to $18.00 and set an "equal weight" rating for the company in a research report on Wednesday, August 27th. Scotiabank downgraded Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and reduced their target price for the stock from $21.00 to $19.00 in a report on Tuesday, July 29th. Robert W. Baird set a $21.00 price target on shares of Healthpeak Properties and gave the company an "outperform" rating in a report on Wednesday, July 30th. Morgan Stanley reduced their price objective on shares of Healthpeak Properties from $22.00 to $21.00 and set an "overweight" rating for the company in a research note on Friday, August 22nd. Finally, Deutsche Bank Aktiengesellschaft reissued a "hold" rating and issued a $18.00 price objective (down from $28.00) on shares of Healthpeak Properties in a research note on Wednesday, August 20th. Seven investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $21.50.
View Our Latest Analysis on Healthpeak Properties
Healthpeak Properties Trading Down 1.2%
Healthpeak Properties stock traded down $0.22 during trading hours on Tuesday, reaching $18.09. The stock had a trading volume of 1,989,683 shares, compared to its average volume of 6,066,410. Healthpeak Properties, Inc. has a 52 week low of $16.63 and a 52 week high of $23.26. The stock has a market cap of $12.57 billion, a PE ratio of 75.23, a PEG ratio of 2.37 and a beta of 1.07. The company has a fifty day simple moving average of $17.77 and a 200-day simple moving average of $18.22. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.28 and a quick ratio of 1.28.
Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings data on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting analysts' consensus estimates of $0.46. The business had revenue of $694.35 million during the quarter, compared to analyst estimates of $697.14 million. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. Healthpeak Properties's revenue was down .2% compared to the same quarter last year. During the same period last year, the business earned $0.45 EPS. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. Analysts forecast that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.
Healthpeak Properties Announces Dividend
The company also recently disclosed a monthly dividend, which was paid on Friday, August 29th. Shareholders of record on Monday, August 18th were given a dividend of $0.1017 per share. The ex-dividend date was Monday, August 18th. This represents a c) dividend on an annualized basis and a yield of 6.7%. Healthpeak Properties's payout ratio is 508.33%.
About Healthpeak Properties
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Articles
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
